CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
8.47
-0.14 (-1.63%)
At close: Sep 3, 2026, 4:00 PM EDT
8.35
-0.12 (-1.45%)
After-hours: Sep 3, 2026, 7:12 PM EDT

CorMedix Revenue

CorMedix had revenue of $101.93M in the quarter ending June 30, 2026, with 156.52% growth. This brings the company's revenue in the last twelve months to $462.25M, up 280.50% year-over-year. In the year 2025, CorMedix had annual revenue of $311.71M with 617.03% growth.

Revenue (ttm)
$462.25M
Revenue Growth
+280.50%
P/S Ratio
1.43
Revenue / Employee
$2,420,152
Employees
191
Market Cap
660.19M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025311.71M268.24M617.03%
Dec 31, 202443.47M--
Dec 31, 2023---
Dec 31, 202265.41K-125.53K-65.74%
Dec 31, 2021190.94K-48.30K-20.19%
Dec 31, 2020239.23K-44.04K-15.55%
Dec 31, 2019283.27K-146.53K-34.09%
Dec 31, 2018429.80K100.47K30.51%
Dec 31, 2017329.33K105.22K46.95%
Dec 31, 2016224.11K13.98K6.65%
Dec 31, 2015210.13K20.86K11.02%
Dec 31, 2014189.27K187.27K9,358.97%
Dec 31, 20132.00K--
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
MiMedx Group355.17M
REGENXBIO174.48M
Autolus Therapeutics117.39M
Verastem87.53M
Assembly Biosciences74.85M
OmniAb38.46M
Prime Medicine4.07M
Altimmune31.00K
Revenue Rankings